Cipher Pharmaceuticals Inc (CPHRF)
6.61
-0.04
(-0.60%)
USD |
OTCM |
May 09, 16:00
Cipher Pharmaceuticals Market Cap: 159.35M for May 9, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 159.35M |
| May 08, 2024 | 160.31M |
| May 07, 2024 | 162.72M |
| May 06, 2024 | 164.17M |
| May 03, 2024 | 159.11M |
| May 02, 2024 | 157.42M |
| May 01, 2024 | 150.67M |
| April 30, 2024 | 151.88M |
| April 29, 2024 | 150.43M |
| April 26, 2024 | 150.19M |
| April 25, 2024 | 150.91M |
| April 24, 2024 | 150.19M |
| April 23, 2024 | 156.70M |
| April 22, 2024 | 149.95M |
| April 19, 2024 | 149.47M |
| April 18, 2024 | 153.18M |
| April 17, 2024 | 154.53M |
| April 16, 2024 | 156.22M |
| April 15, 2024 | 163.69M |
| April 12, 2024 | 163.45M |
| April 11, 2024 | 159.52M |
| April 10, 2024 | 147.17M |
| April 09, 2024 | 148.25M |
| April 08, 2024 | 147.53M |
| April 05, 2024 | 147.53M |
| Date | Value |
|---|---|
| April 04, 2024 | 152.81M |
| April 03, 2024 | 156.40M |
| April 02, 2024 | 147.77M |
| April 01, 2024 | 143.45M |
| March 28, 2024 | 158.10M |
| March 27, 2024 | 163.12M |
| March 26, 2024 | 171.76M |
| March 25, 2024 | 166.24M |
| March 22, 2024 | 161.92M |
| March 21, 2024 | 161.92M |
| March 20, 2024 | 155.69M |
| March 19, 2024 | 143.93M |
| March 18, 2024 | 149.49M |
| March 15, 2024 | 143.12M |
| March 14, 2024 | 126.42M |
| March 13, 2024 | 126.90M |
| March 12, 2024 | 126.90M |
| March 11, 2024 | 127.62M |
| March 08, 2024 | 126.18M |
| March 07, 2024 | 130.02M |
| March 06, 2024 | 127.38M |
| March 05, 2024 | 125.22M |
| March 04, 2024 | 126.90M |
| March 01, 2024 | 127.14M |
| February 29, 2024 | 124.98M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
8.173M
Minimum
Mar 23 2020
171.76M
Maximum
Mar 26 2024
48.89M
Average
39.54M
Median
Mar 10 2022
Market Cap Benchmarks
| Acasti Pharma Inc | 25.94M |
| Aurinia Pharmaceuticals Inc | 739.77M |
| Edesa Biotech Inc | 14.32M |
| Lexaria Bioscience Corp | 46.13M |
| Xenon Pharmaceuticals Inc | 3.203B |
Market Cap Related Metrics
| PE Ratio | 8.367 |
| PS Ratio | 7.946 |
| Price to Book Value | 1.979 |
| Price to Free Cash Flow | 10.51 |
| Price | 6.61 |
| Earnings Yield | 11.95% |
| Operating PE Ratio | 16.76 |
| Normalized PE Ratio | 8.644 |